Mitchell; Steven Chappell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mitchell; Steven Chappell.The latest application filed is for "novel serpentine transmembrane antigens expressed in human cancers and uses thereof".

Company Profile

0.11.8

Mitchell; Steven Chappell - Gurnee IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 8,241,626 - Hubert , et al. August 14, 2	2012-08-14
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20120076724 - Hubert; Rene S. ; et al.	2012-03-29
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,947,459 - Hubert , et al. May 24, 2	2011-05-24
121P1F1: a tissue specific protein highly expressed in various cancers Grant 7,892,548 - Challita-Eid , et al. February 22, 2	2011-02-22
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,727,533 - Afar , et al. June 1, 2	2010-06-01
84P2A9: a prostate and testis specific protein highly expressed in prostate cancer Grant 7,582,448 - Jakobovits , et al. September 1, 2	2009-09-01
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,575,749 - Afar , et al. August 18, 2	2009-08-18
Diagnosis and therapy of cancer using SGP28-related molecules Grant 7,569,356 - Afar , et al. August 4, 2	2009-08-04
121p1f1: A Tissue Specific Protein Highly Expressed In Various Cancers App 20090041756 - CHALLITA-EID; PIA M. ; et al.	2009-02-12
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,455,991 - Afar , et al. November 25, 2	2008-11-25
Antibodies to G protein-coupled receptor Grant 7,351,583 - Raitano , et al. April 1, 2	2008-04-01
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,319,006 - Afar , et al. January 15, 2	2008-01-15
121P1F1: a tissue specific protein highly expressed in various cancers Grant 7,309,585 - Challita-Eid , et al. December 18, 2	2007-12-18
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20070148089 - Hubert; Rene S. ; et al.	2007-06-28
Serpentine transmembrane antigens expressed in human cancers and uses thereof App 20060020113 - Hubert; Rene S. ; et al.	2006-01-26
Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer App 20050214211 - Challita-Eid, Pia M. ; et al.	2005-09-29
Novel gene upregulated in cancers of the prostate App 20050074807 - Afar, Daniel E.H. ; et al.	2005-04-07
Serpentine transmembrane antigens expressed in human cancers and uses thereof App 20050004349 - Hubert, Rene S. ; et al.	2005-01-06
Serpentine transmembrane antigens expressed in human cancers and uses thereof App 20030149531 - Hubert, Rene S. ; et al.	2003-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.